OPIOIDS Act
- Bill Number
- H.R. 1257
- Origin Chamber
- House
- Congress
- 119th Congress, Session 1
- Policy Area
- Crime and Law Enforcement
- Status
- Introduced
- Latest Action
- 2025-02-12: Referred to the House Committee on the Judiciary.
- Last Updated
- 2025-12-06T06:52:23Z
AI-Generated Summary
Purpose
The OPIOIDS Act (H.R. 1257) aims to improve the collection, accuracy, and sharing of data on opioid-related overdoses across the United States. It seeks to enhance surveillance, training, and reporting systems to better track overdoses, support law enforcement efforts, and address gaps in forensic and public health data, ultimately helping to combat the opioid crisis.
Key Provisions
- Grants for Data Improvement (Sec. 2): The Attorney General can provide grants to states, territories, and local governments to enhance opioid overdose data and monitoring. Supported activities include:
- Improving postmortem toxicology testing (examinations after death to detect drugs).
- Linking data across different systems nationwide.
- Training law enforcement officers to handle overdoses and related crimes.
- Implementing electronic reporting of deaths.
- Ensuring more complete data on fatal overdoses.
- Law Enforcement and Forensic Grants (Sec. 3): Grants are available to local law enforcement agencies and forensic labs in areas with high overdose rates for:
- Training officers to recognize overdoses.
- Upgrading lab systems to trace drugs and process samples, with standardized reporting to the National Forensic Laboratory Information System (NFLIS, a federal database for drug analysis).
- Training on tracking criminals via the darknet (hidden online networks used for illegal activities).
- Providing resources like training, staff, and equipment to medical examiners' and coroners' offices (officials who investigate deaths) for faster handling of suspected overdose cases.
- Grantees must report overdose data to NFLIS.
- Federal training centers will offer programs on coordinating with state and federal partners to track drug activities.
- Office of National Drug Control Policy Reform (Sec. 4): The Drug Enforcement Administration (DEA) must create uniform standards for reporting drug details (purity, formulation, and weight) to NFLIS, enabling better comparisons and data sharing across jurisdictions. This does not impose new requirements on state or local labs.
- DEA Testing Funding (Sec. 5): The DEA must include a specific funding request in its annual budget for the Fentanyl Signature Profiling Program (a initiative to analyze fentanyl samples for origin and distribution patterns).
Significant Changes to Existing Law
- Amends Section 1701(b) of the Omnibus Crime Control and Safe Streets Act of 1968 (which funds community policing programs, known as COPS grants) to add a new priority: providing training and resources for containment devices (tools to safely handle substances) to protect first responders from secondary exposure to fentanyl and other drugs during overdose responses.
- Introduces mandatory reporting requirements for grant recipients to NFLIS, tying funding to data submission.
- Establishes new uniform reporting standards by the DEA for NFLIS without creating additional burdens on non-federal labs.
- Requires the DEA to explicitly request funding for the Fentanyl Signature Profiling Program in its budget submissions to Congress.
Potential Impacts
- On Government Agencies: Enhances coordination and data sharing among federal (e.g., DEA, Attorney General's office), state, and local entities, potentially improving resource allocation for overdose response. Federal training centers and budget line items could streamline anti-drug efforts but may increase administrative workload for reporting.
- On Citizens: In high-overdose communities, better training and equipment could lead to faster, safer emergency responses, reducing risks to first responders and improving overdose investigations. More accurate data might inform public health strategies to prevent future overdoses.
- On International Relations: Indirectly supports U.S. efforts against international drug trafficking (e.g., via darknet tracking and fentanyl profiling), potentially aiding cooperation with foreign partners on opioid supply chains, though the bill focuses domestically.
Main Stakeholders
- Law Enforcement and Forensic Personnel: Local agencies, medical examiners, coroners, and federal training centers benefit from grants, training, and equipment upgrades.
- State and Local Governments: Eligible for grants to improve data systems and public health surveillance.
- Federal Agencies: Attorney General's office, DEA, and Office of National Drug Control Policy gain tools for standardized data and budgeting.
- Communities Affected by Opioids: Residents in high-overdose areas, first responders, and public health officials who rely on better data for prevention and response.
- Congress: Receives DEA budget details, influencing oversight of drug control funding.
Notable Legal, Constitutional, or Political Implications
- Legal: Strengthens federal support for state and local efforts without mandating new obligations on non-federal entities, respecting federalism (the division of powers between federal and state governments). The mandatory NFLIS reporting for grantees ensures accountability for federal funds but could raise privacy concerns if not handled carefully (though the bill does not address data protection explicitly).
- Constitutional: Aligns with Congress's authority under the Commerce Clause to regulate interstate drug trafficking and public health crises, without apparent conflicts with individual rights.
- Political: Bipartisan introduction (by Reps. Lee and Pappas) highlights opioid crisis as a non-partisan issue. By amending existing grant programs like COPS, it builds on prior anti-drug laws, potentially easing passage, but funding requests could spark debates over federal spending priorities in budget negotiations.
This summary was generated by AI and may contain inaccuracies. Refer to the official source document for the authoritative text.
Sponsor
Cosponsors (2)
Rep. Pappas, Chris [D-NH-1], Rep. Neguse, Joe [D-CO-2]
Recent Actions
- 2025-02-12: Referred to the House Committee on the Judiciary.
- 2025-02-12: Introduced in House
- 2025-02-12: Introduced in House
Bill Versions
- Overcoming Prevalent Inadequacies in Overdose Information Data Sets Act — issued 2025-02-12 — PDF (4 pages)